Clinical Trial Update: Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating irinotecan for hepatoblastoma in young patients; the document provides an update but the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatoblastoma

Drugs mentioned

• Irinotecan (Irinotecan)

Snippet

Sponsor: Children's Cancer and Leukaemia Group | Conditions: Liver Cancer | Phase 2 | Status: UNKNOWN